Predicting novel binding modes of agonists to β adrenergic receptors using all-atom molecular dynamics simulations.
Understanding the binding mode of agonists to adrenergic receptors is crucial to enabling improved rational design of new therapeutic agents. However, so far the high conformational flexibility of G protein-coupled receptors has been an obstacle to obtaining structural information on agonist binding at atomic resolution. In this study, we report microsecond classical molecular dynamics simulations of β(1) and β(2) adrenergic receptors bound to the full agonist isoprenaline and in their unliganded form. These simulations show a novel agonist binding mode that differs from the one found for antagonists in the crystal structures and from the docking poses reported by in silico docking studies performed on rigid receptors. Internal water molecules contribute to the stabilization of novel interactions between ligand and receptor, both at the interface of helices V and VI with the catechol group of isoprenaline as well as at the interface of helices III and VII with the ethanolamine moiety of the ligand. Despite the fact that the characteristic N-C-C-OH motif is identical in the co-crystallized ligands and in the full agonist isoprenaline, the interaction network between this group and the anchor site formed by Asp(3.32) and Asn(7.39) is substantially different between agonists and inverse agonists/antagonists due to two water molecules that enter the cavity and contribute to the stabilization of a novel network of interactions. These new binding poses, together with observed conformational changes in the extracellular loops, suggest possible determinants of receptor specificity.
Laboratory of Computational Chemistry and Biochemistry, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Stefano
S
Vanni
Marilisa
M
Neri
Ivano
I
Tavernelli
Ursula
U
Rothlisberger
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D001665:Binding Sites; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation
D000318:Adrenergic beta-Agonists
Nat Chem Biol. 2008 Jul;4(7):397-403
18560432
Nat Struct Mol Biol. 2009 Feb;16(2):168-75
19182802
J Comput Chem. 2010 Mar;31(4):707-20
19569204
J Biol Chem. 2000 Dec 1;275(48):37779-88
10964911
J Biol Chem. 1988 Jul 25;263(21):10267-71
2899076
J Biol Chem. 2000 Feb 4;275(5):3121-7
10652295
Biochemistry. 2009 Jun 9;48(22):4789-97
19378975
Biochemistry. 2008 Oct 21;47(42):11013-23
18821775
J Comput Aided Mol Des. 2009 May;23(5):273-88
19148767
J Phys Chem B. 2010 Jul 1;114(25):8374-86
20524635
J Biol Chem. 1988 Mar 25;263(9):4052-5
2831218
Nat Chem Biol. 2006 Aug;2(8):417-22
16799554
J Biol Chem. 1989 Aug 15;264(23):13572-8
2547766
J Comput Chem. 2005 Dec;26(16):1701-18
16211538
Mol Pharmacol. 1998 Oct;54(4):616-22
9765503
J Biol Chem. 2001 Jul 6;276(27):24433-6
11320077
Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):151-9
14730417
Pharmacogenomics J. 2007 Feb;7(1):29-37
16636683
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6843-8
19342484
Chembiochem. 2007 Jan 2;8(1):19-24
17173267
EMBO J. 2009 Nov 4;28(21):3315-28
19763081
J Med Chem. 2008 Aug 28;51(16):4978-85
18680279
Biol Pharm Bull. 2008 Aug;31(8):1517-22
18670082
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
8744570
J Biol Chem. 2004 Jan 2;279(1):686-91
14559905
J Biol Chem. 2010 Jun 18;285(25):19625-36
20395291
Phys Rev A Gen Phys. 1985 Mar;31(3):1695-1697
9895674
Mol Pharmacol. 1993 Jul;44(1):111-4
8101966
Science. 2007 Nov 23;318(5854):1258-65
17962520
Mol Pharmacol. 2008 Nov;74(5):1246-60
18687809
Biophys J. 2010 Jan 6;98(1):76-84
20074514
J Biol Chem. 2005 Jun 10;280(23):22165-71
15817484
J Mol Biol. 2009 Oct 2;392(4):1102-15
19665031
J Mol Recognit. 2009 Jul-Aug;22(4):307-18
19353579
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14367-72
19706523
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9501-6
19470481
Nature. 2010 Jan 7;463(7277):108-12
20054398
J Mol Biol. 2010 Apr 16;397(5):1339-49
20132827
Nature. 2008 Jul 24;454(7203):486-91
18594507
Nature. 1979 Sep 13;281(5727):114-7
38405
Trends Pharmacol Sci. 2007 Aug;28(8):397-406
17629961
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9276-81
8799191